Global Medicines for Eosinophilic Asthma Treatment Market Research Report 2023
Eosinophilic asthma is a type of asthma that is caused by high levels of white blood cells called eosinophils in the airways of the lungs.
According to QYResearch’s new survey, global Medicines for Eosinophilic Asthma Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medicines for Eosinophilic Asthma Treatment market research.
Key companies engaged in the Medicines for Eosinophilic Asthma Treatment industry include AstraZeneca, GSK, Genentech (Roche Group) & Novartis, Regeneron Pharmaceuticals & Sanofi and Teva Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Medicines for Eosinophilic Asthma Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Medicines for Eosinophilic Asthma Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medicines for Eosinophilic Asthma Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Medicines for Eosinophilic Asthma Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medicines for Eosinophilic Asthma Treatment market research.
Key companies engaged in the Medicines for Eosinophilic Asthma Treatment industry include AstraZeneca, GSK, Genentech (Roche Group) & Novartis, Regeneron Pharmaceuticals & Sanofi and Teva Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Medicines for Eosinophilic Asthma Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Medicines for Eosinophilic Asthma Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medicines for Eosinophilic Asthma Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- AstraZeneca
- GSK
- Genentech (Roche Group) & Novartis
- Regeneron Pharmaceuticals & Sanofi
- Teva Pharmaceuticals
- Fasenra
- Nucala
- Cinqair
- Others
- Children
- Adults
- Teenagers
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Fasenra
1.2.3 Nucala
1.2.4 Cinqair
1.2.5 Others
1.3 Market by Application
1.3.1 Global Medicines for Eosinophilic Asthma Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Children
1.3.3 Adults
1.3.4 Teenagers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Medicines for Eosinophilic Asthma Treatment Market Perspective (2018-2029)
2.2 Medicines for Eosinophilic Asthma Treatment Growth Trends by Region
2.2.1 Global Medicines for Eosinophilic Asthma Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Medicines for Eosinophilic Asthma Treatment Historic Market Size by Region (2018-2023)
2.2.3 Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Region (2024-2029)
2.3 Medicines for Eosinophilic Asthma Treatment Market Dynamics
2.3.1 Medicines for Eosinophilic Asthma Treatment Industry Trends
2.3.2 Medicines for Eosinophilic Asthma Treatment Market Drivers
2.3.3 Medicines for Eosinophilic Asthma Treatment Market Challenges
2.3.4 Medicines for Eosinophilic Asthma Treatment Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Medicines for Eosinophilic Asthma Treatment Players by Revenue
3.1.1 Global Top Medicines for Eosinophilic Asthma Treatment Players by Revenue (2018-2023)
3.1.2 Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Medicines for Eosinophilic Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medicines for Eosinophilic Asthma Treatment Revenue
3.4 Global Medicines for Eosinophilic Asthma Treatment Market Concentration Ratio
3.4.1 Global Medicines for Eosinophilic Asthma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medicines for Eosinophilic Asthma Treatment Revenue in 2022
3.5 Medicines for Eosinophilic Asthma Treatment Key Players Head office and Area Served
3.6 Key Players Medicines for Eosinophilic Asthma Treatment Product Solution and Service
3.7 Date of Enter into Medicines for Eosinophilic Asthma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MEDICINES FOR EOSINOPHILIC ASTHMA TREATMENT BREAKDOWN DATA BY TYPE
4.1 Global Medicines for Eosinophilic Asthma Treatment Historic Market Size by Type (2018-2023)
4.2 Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Type (2024-2029)
5 MEDICINES FOR EOSINOPHILIC ASTHMA TREATMENT BREAKDOWN DATA BY APPLICATION
5.1 Global Medicines for Eosinophilic Asthma Treatment Historic Market Size by Application (2018-2023)
5.2 Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Medicines for Eosinophilic Asthma Treatment Market Size (2018-2029)
6.2 North America Medicines for Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
6.4 North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Medicines for Eosinophilic Asthma Treatment Market Size (2018-2029)
7.2 Europe Medicines for Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
7.4 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size (2018-2029)
8.2 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Medicines for Eosinophilic Asthma Treatment Market Size (2018-2029)
9.2 Latin America Medicines for Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
9.4 Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size (2018-2029)
10.2 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Medicines for Eosinophilic Asthma Treatment Introduction
11.1.4 AstraZeneca Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Medicines for Eosinophilic Asthma Treatment Introduction
11.2.4 GSK Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Genentech (Roche Group) & Novartis
11.3.1 Genentech (Roche Group) & Novartis Company Detail
11.3.2 Genentech (Roche Group) & Novartis Business Overview
11.3.3 Genentech (Roche Group) & Novartis Medicines for Eosinophilic Asthma Treatment Introduction
11.3.4 Genentech (Roche Group) & Novartis Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
11.3.5 Genentech (Roche Group) & Novartis Recent Development
11.4 Regeneron Pharmaceuticals & Sanofi
11.4.1 Regeneron Pharmaceuticals & Sanofi Company Detail
11.4.2 Regeneron Pharmaceuticals & Sanofi Business Overview
11.4.3 Regeneron Pharmaceuticals & Sanofi Medicines for Eosinophilic Asthma Treatment Introduction
11.4.4 Regeneron Pharmaceuticals & Sanofi Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
11.4.5 Regeneron Pharmaceuticals & Sanofi Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Detail
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Medicines for Eosinophilic Asthma Treatment Introduction
11.5.4 Teva Pharmaceuticals Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
11.5.5 Teva Pharmaceuticals Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Fasenra
1.2.3 Nucala
1.2.4 Cinqair
1.2.5 Others
1.3 Market by Application
1.3.1 Global Medicines for Eosinophilic Asthma Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Children
1.3.3 Adults
1.3.4 Teenagers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Medicines for Eosinophilic Asthma Treatment Market Perspective (2018-2029)
2.2 Medicines for Eosinophilic Asthma Treatment Growth Trends by Region
2.2.1 Global Medicines for Eosinophilic Asthma Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Medicines for Eosinophilic Asthma Treatment Historic Market Size by Region (2018-2023)
2.2.3 Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Region (2024-2029)
2.3 Medicines for Eosinophilic Asthma Treatment Market Dynamics
2.3.1 Medicines for Eosinophilic Asthma Treatment Industry Trends
2.3.2 Medicines for Eosinophilic Asthma Treatment Market Drivers
2.3.3 Medicines for Eosinophilic Asthma Treatment Market Challenges
2.3.4 Medicines for Eosinophilic Asthma Treatment Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Medicines for Eosinophilic Asthma Treatment Players by Revenue
3.1.1 Global Top Medicines for Eosinophilic Asthma Treatment Players by Revenue (2018-2023)
3.1.2 Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Medicines for Eosinophilic Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medicines for Eosinophilic Asthma Treatment Revenue
3.4 Global Medicines for Eosinophilic Asthma Treatment Market Concentration Ratio
3.4.1 Global Medicines for Eosinophilic Asthma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medicines for Eosinophilic Asthma Treatment Revenue in 2022
3.5 Medicines for Eosinophilic Asthma Treatment Key Players Head office and Area Served
3.6 Key Players Medicines for Eosinophilic Asthma Treatment Product Solution and Service
3.7 Date of Enter into Medicines for Eosinophilic Asthma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MEDICINES FOR EOSINOPHILIC ASTHMA TREATMENT BREAKDOWN DATA BY TYPE
4.1 Global Medicines for Eosinophilic Asthma Treatment Historic Market Size by Type (2018-2023)
4.2 Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Type (2024-2029)
5 MEDICINES FOR EOSINOPHILIC ASTHMA TREATMENT BREAKDOWN DATA BY APPLICATION
5.1 Global Medicines for Eosinophilic Asthma Treatment Historic Market Size by Application (2018-2023)
5.2 Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Medicines for Eosinophilic Asthma Treatment Market Size (2018-2029)
6.2 North America Medicines for Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
6.4 North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Medicines for Eosinophilic Asthma Treatment Market Size (2018-2029)
7.2 Europe Medicines for Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
7.4 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size (2018-2029)
8.2 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Medicines for Eosinophilic Asthma Treatment Market Size (2018-2029)
9.2 Latin America Medicines for Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
9.4 Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size (2018-2029)
10.2 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Medicines for Eosinophilic Asthma Treatment Introduction
11.1.4 AstraZeneca Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Medicines for Eosinophilic Asthma Treatment Introduction
11.2.4 GSK Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Genentech (Roche Group) & Novartis
11.3.1 Genentech (Roche Group) & Novartis Company Detail
11.3.2 Genentech (Roche Group) & Novartis Business Overview
11.3.3 Genentech (Roche Group) & Novartis Medicines for Eosinophilic Asthma Treatment Introduction
11.3.4 Genentech (Roche Group) & Novartis Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
11.3.5 Genentech (Roche Group) & Novartis Recent Development
11.4 Regeneron Pharmaceuticals & Sanofi
11.4.1 Regeneron Pharmaceuticals & Sanofi Company Detail
11.4.2 Regeneron Pharmaceuticals & Sanofi Business Overview
11.4.3 Regeneron Pharmaceuticals & Sanofi Medicines for Eosinophilic Asthma Treatment Introduction
11.4.4 Regeneron Pharmaceuticals & Sanofi Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
11.4.5 Regeneron Pharmaceuticals & Sanofi Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Detail
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Medicines for Eosinophilic Asthma Treatment Introduction
11.5.4 Teva Pharmaceuticals Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
11.5.5 Teva Pharmaceuticals Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Fasenra
Table 3. Key Players of Nucala
Table 4. Key Players of Cinqair
Table 5. Key Players of Others
Table 6. Global Medicines for Eosinophilic Asthma Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Medicines for Eosinophilic Asthma Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Medicines for Eosinophilic Asthma Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Medicines for Eosinophilic Asthma Treatment Market Share by Region (2018-2023)
Table 10. Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Medicines for Eosinophilic Asthma Treatment Market Share by Region (2024-2029)
Table 12. Medicines for Eosinophilic Asthma Treatment Market Trends
Table 13. Medicines for Eosinophilic Asthma Treatment Market Drivers
Table 14. Medicines for Eosinophilic Asthma Treatment Market Challenges
Table 15. Medicines for Eosinophilic Asthma Treatment Market Restraints
Table 16. Global Medicines for Eosinophilic Asthma Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Medicines for Eosinophilic Asthma Treatment Market Share by Players (2018-2023)
Table 18. Global Top Medicines for Eosinophilic Asthma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicines for Eosinophilic Asthma Treatment as of 2022)
Table 19. Ranking of Global Top Medicines for Eosinophilic Asthma Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Medicines for Eosinophilic Asthma Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Medicines for Eosinophilic Asthma Treatment Product Solution and Service
Table 23. Date of Enter into Medicines for Eosinophilic Asthma Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Medicines for Eosinophilic Asthma Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Type (2024-2029)
Table 29. Global Medicines for Eosinophilic Asthma Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Application (2024-2029)
Table 33. North America Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 48. AstraZeneca Company Detail
Table 49. AstraZeneca Business Overview
Table 50. AstraZeneca Medicines for Eosinophilic Asthma Treatment Product
Table 51. AstraZeneca Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023) & (US$ Million)
Table 52. AstraZeneca Recent Development
Table 53. GSK Company Detail
Table 54. GSK Business Overview
Table 55. GSK Medicines for Eosinophilic Asthma Treatment Product
Table 56. GSK Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023) & (US$ Million)
Table 57. GSK Recent Development
Table 58. Genentech (Roche Group) & Novartis Company Detail
Table 59. Genentech (Roche Group) & Novartis Business Overview
Table 60. Genentech (Roche Group) & Novartis Medicines for Eosinophilic Asthma Treatment Product
Table 61. Genentech (Roche Group) & Novartis Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023) & (US$ Million)
Table 62. Genentech (Roche Group) & Novartis Recent Development
Table 63. Regeneron Pharmaceuticals & Sanofi Company Detail
Table 64. Regeneron Pharmaceuticals & Sanofi Business Overview
Table 65. Regeneron Pharmaceuticals & Sanofi Medicines for Eosinophilic Asthma Treatment Product
Table 66. Regeneron Pharmaceuticals & Sanofi Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023) & (US$ Million)
Table 67. Regeneron Pharmaceuticals & Sanofi Recent Development
Table 68. Teva Pharmaceuticals Company Detail
Table 69. Teva Pharmaceuticals Business Overview
Table 70. Teva Pharmaceuticals Medicines for Eosinophilic Asthma Treatment Product
Table 71. Teva Pharmaceuticals Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023) & (US$ Million)
Table 72. Teva Pharmaceuticals Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
Table 1. Global Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Fasenra
Table 3. Key Players of Nucala
Table 4. Key Players of Cinqair
Table 5. Key Players of Others
Table 6. Global Medicines for Eosinophilic Asthma Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Medicines for Eosinophilic Asthma Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Medicines for Eosinophilic Asthma Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Medicines for Eosinophilic Asthma Treatment Market Share by Region (2018-2023)
Table 10. Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Medicines for Eosinophilic Asthma Treatment Market Share by Region (2024-2029)
Table 12. Medicines for Eosinophilic Asthma Treatment Market Trends
Table 13. Medicines for Eosinophilic Asthma Treatment Market Drivers
Table 14. Medicines for Eosinophilic Asthma Treatment Market Challenges
Table 15. Medicines for Eosinophilic Asthma Treatment Market Restraints
Table 16. Global Medicines for Eosinophilic Asthma Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Medicines for Eosinophilic Asthma Treatment Market Share by Players (2018-2023)
Table 18. Global Top Medicines for Eosinophilic Asthma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicines for Eosinophilic Asthma Treatment as of 2022)
Table 19. Ranking of Global Top Medicines for Eosinophilic Asthma Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Medicines for Eosinophilic Asthma Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Medicines for Eosinophilic Asthma Treatment Product Solution and Service
Table 23. Date of Enter into Medicines for Eosinophilic Asthma Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Medicines for Eosinophilic Asthma Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Type (2024-2029)
Table 29. Global Medicines for Eosinophilic Asthma Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Application (2024-2029)
Table 33. North America Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 48. AstraZeneca Company Detail
Table 49. AstraZeneca Business Overview
Table 50. AstraZeneca Medicines for Eosinophilic Asthma Treatment Product
Table 51. AstraZeneca Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023) & (US$ Million)
Table 52. AstraZeneca Recent Development
Table 53. GSK Company Detail
Table 54. GSK Business Overview
Table 55. GSK Medicines for Eosinophilic Asthma Treatment Product
Table 56. GSK Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023) & (US$ Million)
Table 57. GSK Recent Development
Table 58. Genentech (Roche Group) & Novartis Company Detail
Table 59. Genentech (Roche Group) & Novartis Business Overview
Table 60. Genentech (Roche Group) & Novartis Medicines for Eosinophilic Asthma Treatment Product
Table 61. Genentech (Roche Group) & Novartis Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023) & (US$ Million)
Table 62. Genentech (Roche Group) & Novartis Recent Development
Table 63. Regeneron Pharmaceuticals & Sanofi Company Detail
Table 64. Regeneron Pharmaceuticals & Sanofi Business Overview
Table 65. Regeneron Pharmaceuticals & Sanofi Medicines for Eosinophilic Asthma Treatment Product
Table 66. Regeneron Pharmaceuticals & Sanofi Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023) & (US$ Million)
Table 67. Regeneron Pharmaceuticals & Sanofi Recent Development
Table 68. Teva Pharmaceuticals Company Detail
Table 69. Teva Pharmaceuticals Business Overview
Table 70. Teva Pharmaceuticals Medicines for Eosinophilic Asthma Treatment Product
Table 71. Teva Pharmaceuticals Revenue in Medicines for Eosinophilic Asthma Treatment Business (2018-2023) & (US$ Million)
Table 72. Teva Pharmaceuticals Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Medicines for Eosinophilic Asthma Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Medicines for Eosinophilic Asthma Treatment Market Share by Type: 2022 VS 2029
Figure 3. Fasenra Features
Figure 4. Nucala Features
Figure 5. Cinqair Features
Figure 6. Others Features
Figure 7. Global Medicines for Eosinophilic Asthma Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Medicines for Eosinophilic Asthma Treatment Market Share by Application: 2022 VS 2029
Figure 9. Children Case Studies
Figure 10. Adults Case Studies
Figure 11. Teenagers Case Studies
Figure 12. Medicines for Eosinophilic Asthma Treatment Report Years Considered
Figure 13. Global Medicines for Eosinophilic Asthma Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Medicines for Eosinophilic Asthma Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Medicines for Eosinophilic Asthma Treatment Market Share by Region: 2022 VS 2029
Figure 16. Global Medicines for Eosinophilic Asthma Treatment Market Share by Players in 2022
Figure 17. Global Top Medicines for Eosinophilic Asthma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicines for Eosinophilic Asthma Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Medicines for Eosinophilic Asthma Treatment Revenue in 2022
Figure 19. North America Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Medicines for Eosinophilic Asthma Treatment Market Share by Country (2018-2029)
Figure 21. United States Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Medicines for Eosinophilic Asthma Treatment Market Share by Country (2018-2029)
Figure 25. Germany Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Share by Region (2018-2029)
Figure 33. China Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Medicines for Eosinophilic Asthma Treatment Market Share by Country (2018-2029)
Figure 41. Mexico Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Share by Country (2018-2029)
Figure 45. Turkey Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. AstraZeneca Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
Figure 48. GSK Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
Figure 49. Genentech (Roche Group) & Novartis Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
Figure 50. Regeneron Pharmaceuticals & Sanofi Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
Figure 51. Teva Pharmaceuticals Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Figure 1. Global Medicines for Eosinophilic Asthma Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Medicines for Eosinophilic Asthma Treatment Market Share by Type: 2022 VS 2029
Figure 3. Fasenra Features
Figure 4. Nucala Features
Figure 5. Cinqair Features
Figure 6. Others Features
Figure 7. Global Medicines for Eosinophilic Asthma Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Medicines for Eosinophilic Asthma Treatment Market Share by Application: 2022 VS 2029
Figure 9. Children Case Studies
Figure 10. Adults Case Studies
Figure 11. Teenagers Case Studies
Figure 12. Medicines for Eosinophilic Asthma Treatment Report Years Considered
Figure 13. Global Medicines for Eosinophilic Asthma Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Medicines for Eosinophilic Asthma Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Medicines for Eosinophilic Asthma Treatment Market Share by Region: 2022 VS 2029
Figure 16. Global Medicines for Eosinophilic Asthma Treatment Market Share by Players in 2022
Figure 17. Global Top Medicines for Eosinophilic Asthma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicines for Eosinophilic Asthma Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Medicines for Eosinophilic Asthma Treatment Revenue in 2022
Figure 19. North America Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Medicines for Eosinophilic Asthma Treatment Market Share by Country (2018-2029)
Figure 21. United States Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Medicines for Eosinophilic Asthma Treatment Market Share by Country (2018-2029)
Figure 25. Germany Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Share by Region (2018-2029)
Figure 33. China Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Medicines for Eosinophilic Asthma Treatment Market Share by Country (2018-2029)
Figure 41. Mexico Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Share by Country (2018-2029)
Figure 45. Turkey Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Medicines for Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. AstraZeneca Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
Figure 48. GSK Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
Figure 49. Genentech (Roche Group) & Novartis Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
Figure 50. Regeneron Pharmaceuticals & Sanofi Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
Figure 51. Teva Pharmaceuticals Revenue Growth Rate in Medicines for Eosinophilic Asthma Treatment Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
